z-logo
open-access-imgOpen Access
Adenocarcinoma of the third duodenal portion: Case report and review of literature
Author(s) -
Federico Sista,
Giuseppe De Santis,
Antonio Giuliani,
Emanuela Marina Cecilia,
Federica Piccione,
Laura Lancione,
S Leardi,
Gianfranco Amicucci
Publication year - 2012
Publication title -
world journal of gastrointestinal surgery
Language(s) - English
Resource type - Journals
ISSN - 1948-9366
DOI - 10.4240/wjgs.v4.i1.23
Subject(s) - medicine , duodenum , adenocarcinoma , duodenal cancer , surgery , lymph , endoscopy , biopsy , pancreatectomy , incidence (geometry) , general surgery , radiology , resection , cancer , pathology , physics , optics
We focus on the diagnostic and therapeutic problems of duodenal adenocarcinoma, reporting a case and reviewing the literature. A 65-year old man with adenocarcinoma in the third duodenal portion was successfully treated with a segmental resection of the third part of the duodenum, avoiding a duodeno-cephalo-pancreatectomy. This tumor is very rare and frequently affects the III and IV duodenal portion. A precocious diagnosis and the exact localization of this neoplasia are crucial factors in order to decide the surgical strategy. Given a non-specificity of symptoms, endoscopy with biopsy is the diagnostic gold standard. Duodeno-cephalo-pancreatectomy (DCP) and segmental resection of the duodenum (SRD) are the two surgical options, with overlapping morbidity (27% vs 18%) and post operative mortality (3% vs 1%). The average incidence of postoperative long-term survival is 100%, 73.3% and 31.6% of cases after 1, 3 and 5 years from surgery, respectively. Long-term survival is made worse by two factors: the presence of metastatic lymph nodes and tumor localization in the proximal duodenum. The two surgical options are radical: DCP should be used only for proximal localizations while SRD should be chosen for distal localizations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here